Risk of Serious Infection With Adalimumab in Hidradenitis Suppurativa Compared With Psoriasis.

Saved in:
Bibliographic Details
Title: Risk of Serious Infection With Adalimumab in Hidradenitis Suppurativa Compared With Psoriasis.
Authors: Wafae BGO; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Beth Israel Deaconess Medical Center, Boston, Massachusetts., Charrow AP; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Stein D; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts., Barbieri JS; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Associate Editor and Evidence-based Practice Editor, JAMA Dermatology., Noe MH; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Sanofi Pharmaceuticals, Boston, Massachusetts.
Source: JAMA dermatology [JAMA Dermatol] 2025 Nov 01; Vol. 161 (11), pp. 1116-1122.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2168-6084
DOI:10.1001/jamadermatol.2025.2881